ASA challenges retailers falsely claiming UK presence
ASA finds ads misleading for implying that advertisers based overseas were based in the UK and omitting the marketers’ geographical addresses.
All Articles in Prices
Via no-go on its pricing claims
The ASA has ruled against Viagogo’s claim that “over half the events listed on Viagogo had tickets selling below face value,” finding it misleading. Gregory Barton and Thuvaraka Balamurali reports.
Understanding advertising: the UK's ad concerns
The ASA’s latest report sheds light on public concerns about advertising, focusing on context, portrayal and misleadingness. Alex Lowe reports.
Sun, sea and savings: Haven’s misleading price claims
The ASA rules that unsubstantiated “from” price claims are misleading. Sophie Chesterman reports.
Advertising codes updated: how the DMCCA has impacted the advertising codes
CAP and BCAP codes have been amended following the UCPs provisions in the DMCCA coming into force on 6 April 2025. Josephine O’Dowd reports.
Something smells off: ASA ruling on misleading perfume prices
The ASA has considered whether a price claim on a perfume sample was misleading and the use of a “from” price. Aisling Farley reports.
Ringing in the changes: updated guidance on presenting mid-contract price rises in telecoms ads
Four the record: ISBA & IMTB’s Influencer Marketing Code hits version 4
KeyForHer food supplements: key reminders for claims targeted at those experiencing menopause
ASA rules against a food supplement manufacturer’s exaggerated re-wording of an authorised claim, Stefanie Lo reports.
CMA publishes update on its work on loyalty pricing in the groceries sector
The CMA publishes an update on its work on loyalty pricing in the groceries sector. Melissa Woodfield reports.
CMA is heating up on the green heating and insulation sector
The CMA publishes final advice for marketing green heating and insulation products, Emily Addleman reports.
English High Court considers when ads are comparative by implication
English High Court considers when ads could be considered comparative in nature, composition, efficacy and/or quality by implication. Anna Matsiienko and Louisa Morrison report.
